AHSC - Imperial College Academic Health Science Centre ☰ Menu
  • About Imperial College AHSC
    • The AHSC Partners
    • How we work
    • Our history
    • Our Impact
    • Imperial College Health Partners
  • Our Vision and Strategy
  • Research Disease Areas
    • Cancer
    • Infection and antimicrobial resistance
    • Cardiovascular
    • Lung disease
    • Metabolic Medicine
    • Neurological and neurodegenerative disease
  • Education and Learning
  • AHSC Seminars
  • News & Events
  • Contact us
Search
  • About this site
  • Cookies policy

© 2022 Imperial College Academic Health Science Centre

Imperial College Academic Health Science Centre

Home » News » Boosters vital to mitigate impact of Omicron, but may lose some effectiveness

Boosters vital to mitigate impact of Omicron, but may lose some effectiveness

  • Share
  • Share on Twitter
  • Share on Facebook
  • Share on LinkedIn

Related News

June 20, 2022 Imperial joins UK’s top scientists to battle bird flu outbreaks
June 14, 2022 Omicron infection is a poor booster of COVID-19 immunity
May 20, 2022 Monkeypox outbreak – an Imperial expert explains